Wormiza 222 mg contains Fenbendazole, an anthelmintic (deworming) medication primarily used in veterinary medicine to treat parasitic infections in animals. It is commonly administered to dogs, cats, and livestock to eliminate intestinal worms such as roundworms, hookworms, and whipworms. While there has been growing interest in Fenbendazole for potential human use—particularly due to anecdotal claims linking it to cancer treatment—its use in humans remains unapproved and unregulated.
Currently, Fenbendazole is not officially approved by medical authorities like the FDA for human consumption. However, some individuals have self-administered veterinary formulations of Fenbendazole, such as Wormiza 222 mg, often inspired by online testimonials and experimental approaches. This practice carries potential risks, including incorrect dosing, contamination, or adverse effects, since veterinary medications are not subject to the same stringent safety standards as human pharmaceuticals.
In summary, while Wormiza 222 mg (Fenbendazole) is not designed or approved for human use, some people have used it off-label. Anyone considering this should consult a qualified healthcare provider before use. Self-medication without proper guidance can be dangerous and is not recommended. Clinical research is ongoing to evaluate the safety and efficacy of Fenbendazole in humans.
